Cargando…

The role of neuroimaging in Parkinson’s disease

Parkinson's disease (PD) is a neurodegenerative disorder that affects millions of people worldwide. Two hallmarks of PD are the accumulation of alpha‐synuclein and the loss of dopaminergic neurons in the brain. There is no cure for PD, and all existing treatments focus on alleviating the sympto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bidesi, Natasha S. R., Vang Andersen, Ida, Windhorst, Albert D., Shalgunov, Vladimir, Herth, Matthias M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291628/ https://www.ncbi.nlm.nih.gov/pubmed/34532856 http://dx.doi.org/10.1111/jnc.15516

Ejemplares similares

Synthesis and radiolabeling of a polar [(125)I]I‐1,2,4,5‐tetrazine
por: Bidesi, Natasha, et al.
Publicado: (2022)

Pretargeted Imaging beyond the Blood–Brain Barrier—Utopia or Feasible?
por: Lopes van den Broek, Sara, et al.
Publicado: (2022)

Development of the First Tritiated Tetrazine: Facilitating Tritiation of Proteins
por: Radjani Bidesi, Natasha Shalina, et al.
Publicado: (2022)

Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts
por: Korat, Špela, et al.
Publicado: (2021)

Neuroimaging in pre-motor Parkinson's disease()
por: Barber, Thomas R., et al.
Publicado: (2017)

Optimization of Direct Aromatic (18)F-Labeling of Tetrazines
por: Andersen, Ida Vang, et al.
Publicado: (2022)

Can neuroimaging predict dementia in Parkinson’s disease?
por: Lanskey, Juliette H, et al.
Publicado: (2018)

The Structural Combination of SIL and MODAG Scaffolds Fails to Enhance Binding to α-Synuclein but Reveals Promising Affinity to Amyloid β
por: Di Nanni, Adriana, et al.
Publicado: (2023)

Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
por: Zhang, Yu, et al.
Publicado: (2023)

Sensorimotor Connectivity in Parkinson’s Disease: The Role of Functional Neuroimaging
por: Tessitore, Alessandro, et al.
Publicado: (2014)

Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson’s Disease
por: Raval, Nakul Ravi, et al.
Publicado: (2021)

Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease
por: Hanganu, Alexandru, et al.
Publicado: (2016)

Neuroimaging in Parkinson’s disease dementia: connecting the dots
por: Weil, Rimona S, et al.
Publicado: (2019)

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review
por: Carey, Guillaume, et al.
Publicado: (2020)

The Parkinson's Disease Progression Neuroimaging Initiative
por: Zhu, Shiyi, et al.
Publicado: (2021)

Evaluation of [(64)Cu]Cu-NOTA-PEG(7)-H-Tz for Pretargeted Imaging in LS174T Xenografts—Comparison to [(111)In]In-DOTA-PEG(11)-BisPy-Tz
por: Poulie, Christian B. M., et al.
Publicado: (2021)

Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with Pathophysiology
por: Pizarro-Galleguillos, Benjamin Matís, et al.
Publicado: (2023)

Pretargeted imaging beyond the blood–brain barrier
por: Shalgunov, Vladimir, et al.
Publicado: (2022)

Insights into Elution of Anion Exchange Cartridges: Opening the Path toward Aliphatic (18)F-Radiolabeling of Base-Sensitive Tracers
por: Bratteby, Klas, et al.
Publicado: (2021)

Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies
por: Wen, M.‐C., et al.
Publicado: (2016)

Convenient Entry to (18)F‐Labeled Amines through the Staudinger Reduction
por: Stéen, E. Johanna L., et al.
Publicado: (2019)

Neuroimaging Techniques in Differentiating Parkinson’s Disease from Drug-Induced Parkinsonism: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)

Neuroimaging in Vascular Parkinsonism
por: Ma, Karen K. Y., et al.
Publicado: (2019)

Neuroimaging in Parkinsonism: Insights and Challenges
por: Sharma, Vibhash D.
Publicado: (2023)

Neuroimaging advances in Parkinson's disease with freezing of gait: A systematic review
por: Bharti, Komal, et al.
Publicado: (2019)

Action and emotion perception in Parkinson’s disease: A neuroimaging meta-analysis
por: Arioli, Maria, et al.
Publicado: (2022)

Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson’s disease
por: Hirano, Shigeki
Publicado: (2021)

Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
por: Pizarro-Galleguillos, Benjamin Matis, et al.
Publicado: (2022)

Development of (18)F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging
por: García-Vázquez, Rocío, et al.
Publicado: (2022)

The diagnostic potential of multimodal neuroimaging measures in Parkinson's disease and atypical parkinsonism
por: Park, Chang‐hyun, et al.
Publicado: (2020)

Action/Verb processing: Debates in neuroimaging and the contribution of studies in patients with Parkinson's disease
por: da Silva, Henrique Salmazo, et al.
Publicado: (2014)

Neuroimaging Detectable Differences between Parkinson's Disease Motor Subtypes: A Systematic Review
por: Boonstra, Jackson Tyler, et al.
Publicado: (2020)

Cognitive Rehabilitation in Parkinson’s Disease: Evidence from Neuroimaging
por: Nombela, Cristina, et al.
Publicado: (2011)

Neuroimaging and neuropsychological assessment of freezing of gait in Parkinson's disease
por: Bluett, Brent, et al.
Publicado: (2018)

Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
por: Saeed, Usman, et al.
Publicado: (2020)

The role of neuroimaging in acute stroke
por: Dhamija, Rajinder K., et al.
Publicado: (2008)

Neuroimaging studies of striatum in cognition part II: Parkinson's disease
por: Hanganu, Alexandru, et al.
Publicado: (2015)

The Role of the Cerebellum in Tremor – Evidence from Neuroimaging
por: van den Berg, Kevin R. E., et al.
Publicado: (2021)

Neuroimaging signatures predicting motor improvement to focused ultrasound subthalamotomy in Parkinson’s disease
por: Lin, Sue-Jin, et al.
Publicado: (2022)

Blocking of efflux transporters in rats improves translational validation of brain radioligands
por: Shalgunov, Vladimir, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p22ru1ffh6vmm0gro6491h7jhc